Abel Hall, LLC

SEC CIK: 0002013339
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

AKBA holding history

Akebia Therapeutics, Inc. in every 13F filed by Abel Hall, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKBA overview All 13F holders of AKBA Full Q2 2026 holdings

Shares (Q2 2026): 75,438
Value: $86.0K
% of portfolio: <0.1%
Quarters held: 3; Since Q2 2025

Holdings of AKBA by Abel Hall, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	75,438	$86.0K	<0.1%	+75,438	New	Holders
Q4 2025	0	$0	0.0%	−10,500−100.0%	Sold out	Holders
Q3 2025	10,500	$28.7K	<0.1%	−118−1.1%	Reduced	Holders
Q2 2025	10,618	$38.6K	<0.1%	+10,618	New	Holders